DNA 이중나선파손의 수복 과정과 이와 연관된 두경부암 발생 유전자
PATHWAYS AND GENES OF DNA DOUBLE-STRAND BREAK REPAIR ASSOCIATED WITH HEAD AND NECK CANCER
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
DNA double-strand breaks (DSBs) occur commonly in the all living and in cycling cells. They constitute one of the most severe form of DNA damage, because they affect both strand of DNA. DSBs result in cell death or a genetic alterations including deletion, loss of heterozygosity, translocation, and chromosome loss. DSBs arise from endogenous sources like metabolic products and reactive oxygen, and also exogenous factors like ionizing radiation. Defective DNA DSBs can lead to toxicity and large scale sequence rearrangement that can cause cancer and promote premature aging. There are two major pathways for their repair: homologous recombination(HR) and non-homologous end-joining(NHEJ). The HR pathway is a known“ error-free”repair mechanism, in which a homologous sister chromatid serves as a template. NHEJ, on the other hand, is a“ error-prone”pathway, in which the two termini of the broken DNA molecule are used to form compatible ends that are directly ligated. This review aims to provide a fundamental understanding of how HR and NHEJ pathways operate, cause genome instability, and what kind of genes during the pathways are associated with head and neck cancer.
Abstract
DNA double-strand breaks (DSBs) occur commonly in the all living and in cycling cells. They constitute one of the most severe form of DNA damage, because they affect both strand of DNA. DSBs result in cell death or a genetic alterations including deletion, loss of heterozygosity, translocation, and chromosome loss. DSBs arise from endogenous sources like metabolic products and reactive oxygen, and also exogenous factors like ionizing radiation. Defective DNA DSBs can lead to toxicity and large scale sequence rearrangement that can cause cancer and promote premature aging. There are two major pathways for their repair: homologous recombination(HR) and non-homologous end-joining(NHEJ). The HR pathway is a known“ error-free”repair mechanism, in which a homologous sister chromatid serves as a template. NHEJ, on the other hand, is a“ error-prone”pathway, in which the two termini of the broken DNA molecule are used to form compatible ends that are directly ligated. This review aims to provide a fundamental understanding of how HR and NHEJ pathways operate, cause genome instability, and what kind of genes during the pathways are associated with head and neck cancer.
참고문헌 (31)
- Shrivastav M, "Regulation of DNA double-strand break repair pathway choice", Cell Res, 18, pp.134~147 (2008)
- Helleday T, "DNA doublestrand break repair; From mechanistic understanding to cancer treatment", DNA repair, 6, pp.923~935 (2007)
- Strathern JN, "DNA synthesis errors associated with double-strand break repair", Genetics, 140, pp.965~972 (1995)
- Nickoloff JA, "Recombination: mechanisms and roles in tumorigenesis 2nd ed", pp.49~60 (2002), Elsevier Science
- Paull TT, "A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage", Curr Biol, 10, pp.886~895 (2000)
- Venkitaraman AR, "Cancer susceptibility and the functions of BRCA1 and BRCA2", Cell, 108, pp.171~182 (2002)
- Rogakou EP, "DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139", J Biol Chem, 273, pp.5858~5868 (1998)
- Singleton BK, "The C terminus of Ku80 activates the DNA-dependent protein kinase catalytic subunit", Mol Cell Biol, 19, pp.3267~3277 (1999)
- Khanna KK, "DNA double-strand breaks: signaling, repair and the cancer connection", Nat Genet, 27, pp.247~254 (2001)
- Cann KL, "Regulation of the cellular DNA doublestrand break response", Biochem Cell Biol, 85, pp.663~674 (2007)
- Weterings E, "The endless tale of none-homologous end-joining", Cell Res, 18, pp.114~124 (2008)
- Buck D, "Cernunnos, a novel nonhomologous end-joining factor, is mutated in human immunodeficiency with microcephaly", Cell, 124, pp.287~299 (2006)
- Ahnesorg P, "XLP interacts with the XRCC4- DNA ligase IV complex to promote DNA nonhomologous end joining", Cell, 124, pp.301~313 (2006)
- Pfeiffer P, "Pathways of DNA double-strand break repair and their impact on the prevention and formation of chromosomal aberration", Cytogenet Genome Res, 104, pp.7~13 (2004)
- Haber JE, "DNA repair. Gatekeepers of recombination", Nature, 398, pp.665~ (1999)
- Sonoda E, "Differential usage of non-homologous end joining and homologous recombination in double strand break repair", DNA repair, 8, pp.1021~1029 (2006)
- Toone WM, "Getting started: regulating the initiation of DNA replication in yeast", Annu Rev Microbiol, 51, pp.125~149 (1997)
- Lim DS, "Analysis of ku80-mutant mice and cells with deficient levels of p53", Mol Cell Biol, 20, pp.3772~3780 (2000)
- Jhappan C, "A T-cell tumor suppressor encoded at the mouse scid locus", Nat Genet, 17, pp.483~486 (1997)
- Benhamou S, "DNA repair gene XRCC2 and XRCC3 polymorphisms and susceptibility to cancers of the upper aerodigestive tract", Int J Cancer, 112, pp.901~904 (2004)
- Masson JY, "Complex formation by the human RAD51C and XRCC3 recombination repair proteins", Proc Natl Acad Sci USA, 98, pp.8440~8446 (2001)
- Shen MR, "Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans", Cancer Res, 58, pp.604~608 (1998)
- Shen H, "A variant of the DNA repair gene XRCC3 and risk of squamous cell carcinoma of the head and neck: a case-conrol analysis", Int J Cancer, 99, pp.869~872 (2002)
- Gao Y, "A critical role for DNA end-joining proteins in both lymphogenesis and neurogenesis", Cell, 95, pp.891~902 (1998)
- Chiu CF, "A novel single nucleotide polymorphism in XRCC4 gene is associated with oral cancer susceptibility in Taiwanese patients", Oral Oncol (2007)
- Bau DT, "Oral cancer and genetic polymorphism of DNA double strand break gene Ku70 in Taiwan", Oral Oncol (2008)
- Jasin M, "Homologous repair of DNA damage and tumorigenesis: the BRCA connection", Oncogene, 21, pp.8981~8993 (2002)
- Vora HH, "BRCA1 expression in leukoplakia and carcinoma of the tongue", J Surg Oncol, 83, pp.232~240 (2003)
- Lin Y, "Suppression of high-fidelity double-strand break repair in mammalian chromosomes by pifithrin- alpha, a chemical inhibitor of p53", DNA Repair, 2, pp.1~11 (2003)
- Vora HH, "p53 expression in leukoplakia and carcinoma of the tongue", Int J Biol Markers, 21, pp.74~80 (2006)
- Shen H, "P53 codon 72 polymorphism and risk of squamous cell carcinoma of the head and neck: a case-control study", Cancer Lett, 183, pp.123~130 (2002)